Correspondence 0001493152-24-004142 from BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Corp.
Date: Jan. 29, 2024 · CIK: 0001610820 · Accession: 0001493152-24-004142

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-276650

Date

January 22, 2024

Author

William V. Williams

Form

CORRESP

Company

BriaCell Therapeutics Corp.

Letter

Re: BriaCell Therapeutics Corp.

January 29, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street NE

Washington, D.C. 20549

Attention: Alan Campbell

Registration Statement on Form S-3

File No. 333-276650

Filed January 22, 2024

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), BriaCell Therapeutics Corp. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to accelerate the effective date of the above-referenced registration statement (the “Registration Statement”) so as to become effective on Wednesday, January 31, 2024, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by calling Avital Perlman, Esq. at 212-930-9700.

Very
truly yours,
/s/
William V. Williams

Show Raw Text

CORRESP
1
filename1.htm

January
29, 2024

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street NE

Washington,
D.C. 20549

Attention:
Alan Campbell

    Re:
    BriaCell
    Therapeutics Corp.

    Registration
    Statement on Form S-3

    File
    No. 333-276650

    Filed
    January 22, 2024

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), BriaCell Therapeutics
Corp. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”)
take appropriate action to accelerate the effective date of the above-referenced registration statement (the “Registration Statement”)
so as to become effective on Wednesday, January 31, 2024, at 5:00 p.m. Eastern Time, or as soon thereafter as practicable. Once the Registration
Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by calling
Avital Perlman, Esq. at 212-930-9700.

    Very
    truly yours,

    /s/
    William V. Williams

    William V. Williams

                                                                              Chief Executive Officer

SecProbe.io